MedTrace Logo

Ectoin® Lozenges in the Treatment of Acute Viral Pharyngitis

NCT02669446 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2016-06-21

No results posted yet for this study

Summary

This a comparative, open label, parallel group, non interventional study which compares the tolerability and influence of Ectoin containing Lozenges to saline solution and lozenges containing hyaluronic acid for the treatment of acute viral Pharyngitis. The observation takes place over a period of 7 days. Response to treatment is recorded at day 1 and day 7 by the physician and by the patient in a dairy.

Conditions

  • Acute Viral Pharyngitis

Interventions

DEVICE

Medical devices

DEVICE

traditional household remedy

Sponsors & Collaborators

  • Bitop AG

    lead INDUSTRY

Principal Investigators

  • Uwe Sonnemann, MD · HNO-Praxis

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2016-05-31
Completion
2016-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02669446 on ClinicalTrials.gov